Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Plasticell Signs Screening Collaboration With UCB

November 15, 2010 7:42 am | News | Comments

Plasticell, the biotechnology company specialising in the use of innovative high throughput technologies in stem cell research, has announced signing of a collaboration agreement with the biopharmaceutical company, UCB.


Scientists Find Sequences Linked to Heart Beat

November 15, 2010 7:29 am | News | Comments

Scientists studying genetic data have uncovered several DNA sequence variations associated with the electrical impulses that make the heart beat. The findings may pave the way for a greater understanding of the mechanisms for abnormal heart rhythms and sudden cardiac death.


Vitamin D Deficiency Doubles Stroke Risk

November 15, 2010 7:22 am | News | Comments

Low levels of vitamin D, the essential nutrient obtained from milk, fortified cereals and exposure to sunlight, doubles the risk of stroke in whites, but not in blacks, according to a new report by researchers at Johns Hopkins.


Doctors Brace for Medicare Pay Cuts

November 15, 2010 7:15 am | by Ricardo Alnso-Zaldivar | News | Comments

Breast cancer surgeon Kathryn Wagner has posted a warning in her waiting room about a different sort of risk to patients' health: She'll stop taking new Medicare cases if Congress allows looming cuts in doctors' pay to go through.


Omega-3 No Help in Atrial Fibrillation

November 15, 2010 7:10 am | News | Comments

New research shows that taking fish oil capsules does not prevent flare-ups of a common heart rhythm problem as doctors had hoped it would. It was the first rigorous test of omega-3 capsules for atrial fibrillation, when the heart quivers instead of beating normally.


Inspra Trumps Natrecor in Heart Failure

November 15, 2010 6:47 am | by Marilynn Marchione | News | Comments

Millions of people with mild or moderate heart failure got good news, with studies showing a Pfizer drug and a device from Medtronic can boost survival and cut trips to the hospital by patients having trouble breathing.


New Blood Thinner As Effective As Coumadin

November 15, 2010 6:43 am | by Marilynn Marchione | News | Comments

A study finds that a new and easier-to-use blood thinner prevents strokes in people with a common heart rhythm problem as well as Coumadin does, and without an increase in bleeding or side effects.


Sequencer for Cancer Biology and Genetic Disease Research

November 12, 2010 7:26 am | Product Releases | Comments

Life Technologies Corporation inroduced the 5500xl SOLiD Sequencer, a new instrument designed to deliver the industry's fastest and most accurate genomic data for cancer biology and genetic disease research.


Electronic Laboratory Notebook

November 12, 2010 7:22 am | Product Releases | Comments

Celerion announces implementation of the electronic laboratory notebook, Labnotes, a commercially available electronic laboratory notebook system to standardize bioanalytical processes and improve documentation consistency for all studies.


Study: Major Acne Problem May Raise Suicide Risk

November 12, 2010 7:19 am | News | Comments

People with severe acne may be at higher risk of attempting suicide, a new study says.


Common Diabetes Drug May Halt Growth of Cysts in PKD

November 12, 2010 7:16 am | News | Comments

Researchers report that a drug commonly used to treat diabetes may also retard the growth of fluid-filled cysts of the most common genetic disorder, polycystic kidney disease.


Chiral Technologies Celebrates 20 Years Advancing Technology

November 12, 2010 7:10 am | News | Comments

In 1990, Chiral Technologies, Inc. (CTI) opened its doors as a corporation to do its part in transforming separation science by advancing innovative technology for enantioselective chromatography.


eVol Receives 2010 R & D 100 Technology Innovation Award

November 12, 2010 7:02 am | News | Comments

eVol, the world’s first automated analytical syringe created and manufactured by SGE Analytical Science, received its 2010 R&D100 Award at the Award banquet in Orlando, Fla. on November 11.


FDA Authorizes Phase 2 Trial of MultiStem

November 12, 2010 6:57 am | News | Comments

Athersys, Inc. announced that the FDA has authorized commencement of a Phase 2 clinical trial evaluating the safety and efficacy of administration of MultiStem, Athersys' allogeneic investigational cell therapy product.


Abbott Reports Analysis of HUMIRA Studies

November 12, 2010 6:54 am | News | Comments

Abbott presented results from a pooled analysis of two pivotal HUMIRA (adalimumab) studies, which look at patients with early and long-standing moderate to severe rheumatoid arthritis.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.